Global Pigmentation Disorders Treatment Market to Reach $10.1 Billion by 2030

New York, April 14, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pigmentation Disorders Treatment Industry" - https://www.reportlinker.com/p06044794/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Pigmentation Disorders Treatment Market to Reach $10.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Pigmentation Disorders Treatment estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$10.1 Billion by 2030, growing at aCAGR of 5.7% over the period 2022-2030. Topical Drugs, one of the segments analyzed in the report, is projected to record 6.7% CAGR and reach US$4.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Laser Therapy segment is readjusted to a revised 5.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 8.8% CAGR

The Pigmentation Disorders Treatment market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 5.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Select Competitors (Total 41 Featured)
- Allergan PLC
- Bayer AG
- Epipharm AG
- Galderma SA
- Obagi Cosmeceuticals LLC (Obagi Medical)
- Pierre Fabre SA
- RXi Pharmaceuticals Corporation
- SkinCeuticals
- Vivier Pharma, Inc.


Read the full report: https://www.reportlinker.com/p06044794/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Pigmentation Disorders Treatment - Global Key Competitors
Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Pigmentation Disorders
Treatment by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Pigmentation Disorders
Treatment by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2014,
2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Topical Drugs by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Topical Drugs by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Topical Drugs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for Laser
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Laser Therapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Laser Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Chemical Peels by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Chemical Peels by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Chemical Peels by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Phototherapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Phototherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Phototherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Microdermabrasion by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Microdermabrasion by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Microdermabrasion by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Other Treatments by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Other Treatments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Other Treatments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Vitiligo by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Vitiligo by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Vitiligo by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Albinism by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Albinism by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for Albinism by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Other Disease Indications by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Other Disease Indications
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 30: World 16-Year Perspective for Other Disease
Indications by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 32: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 33: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Aesthetic Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 35: World Historic Review for Aesthetic Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 36: World 16-Year Perspective for Aesthetic Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 37: World Recent Past, Current & Future Analysis for
Dermatology Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 38: World Historic Review for Dermatology Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 39: World 16-Year Perspective for Dermatology Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 40: World Pigmentation Disorders Treatment Market
Analysis of Annual Sales in US$ Million for Years 2014 through
2030

III. MARKET ANALYSIS

UNITED STATES
Pigmentation Disorders Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 41: USA Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 43: USA 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,
Microdermabrasion and Other Treatments for the Years 2014, 2023 &
2030

Table 44: USA Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 45: USA Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 46: USA 16-Year Perspective for Pigmentation Disorders
Treatment by Disease Indication - Percentage Breakdown of Value
Sales for Vitiligo, Albinism and Other Disease Indications for
the Years 2014, 2023 & 2030

Table 47: USA Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 48: USA Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 49: USA 16-Year Perspective for Pigmentation Disorders
Treatment by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Aesthetic Clinics and Dermatology Centers for the
Years 2014, 2023 & 2030

CANADA
Table 50: Canada Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 51: Canada Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 52: Canada 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,
Microdermabrasion and Other Treatments for the Years 2014, 2023 &
2030

Table 53: Canada Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 54: Canada Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 55: Canada 16-Year Perspective for Pigmentation Disorders
Treatment by Disease Indication - Percentage Breakdown of Value
Sales for Vitiligo, Albinism and Other Disease Indications for
the Years 2014, 2023 & 2030

Table 56: Canada Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 57: Canada Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 58: Canada 16-Year Perspective for Pigmentation Disorders
Treatment by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Aesthetic Clinics and Dermatology Centers for the
Years 2014, 2023 & 2030

JAPAN
Pigmentation Disorders Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 59: Japan Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 61: Japan 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,
Microdermabrasion and Other Treatments for the Years 2014, 2023 &
2030

Table 62: Japan Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 63: Japan Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 64: Japan 16-Year Perspective for Pigmentation Disorders
Treatment by Disease Indication - Percentage Breakdown of Value
Sales for Vitiligo, Albinism and Other Disease Indications for
the Years 2014, 2023 & 2030

Table 65: Japan Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 66: Japan Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 67: Japan 16-Year Perspective for Pigmentation Disorders
Treatment by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Aesthetic Clinics and Dermatology Centers for the
Years 2014, 2023 & 2030

CHINA
Pigmentation Disorders Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 68: China Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: China Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 70: China 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,
Microdermabrasion and Other Treatments for the Years 2014, 2023 &
2030

Table 71: China Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 72: China Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 73: China 16-Year Perspective for Pigmentation Disorders
Treatment by Disease Indication - Percentage Breakdown of Value
Sales for Vitiligo, Albinism and Other Disease Indications for
the Years 2014, 2023 & 2030

Table 74: China Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 75: China Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 76: China 16-Year Perspective for Pigmentation Disorders
Treatment by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Aesthetic Clinics and Dermatology Centers for the
Years 2014, 2023 & 2030

EUROPE
Pigmentation Disorders Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 77: Europe Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 78: Europe Historic Review for Pigmentation Disorders
Treatment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 79: Europe 16-Year Perspective for Pigmentation Disorders
Treatment by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2014, 2023 & 2030

Table 80: Europe Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 82: Europe 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,
Microdermabrasion and Other Treatments for the Years 2014, 2023 &
2030

Table 83: Europe Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 84: Europe Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 85: Europe 16-Year Perspective for Pigmentation Disorders
Treatment by Disease Indication - Percentage Breakdown of Value
Sales for Vitiligo, Albinism and Other Disease Indications for
the Years 2014, 2023 & 2030

Table 86: Europe Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 87: Europe Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 88: Europe 16-Year Perspective for Pigmentation Disorders
Treatment by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Aesthetic Clinics and Dermatology Centers for the
Years 2014, 2023 & 2030

FRANCE
Pigmentation Disorders Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 89: France Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 90: France Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 91: France 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,
Microdermabrasion and Other Treatments for the Years 2014, 2023 &
2030

Table 92: France Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 93: France Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 94: France 16-Year Perspective for Pigmentation Disorders
Treatment by Disease Indication - Percentage Breakdown of Value
Sales for Vitiligo, Albinism and Other Disease Indications for
the Years 2014, 2023 & 2030

Table 95: France Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 96: France Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 97: France 16-Year Perspective for Pigmentation Disorders
Treatment by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Aesthetic Clinics and Dermatology Centers for the
Years 2014, 2023 & 2030

GERMANY
Pigmentation Disorders Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 98: Germany Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 99: Germany Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 100: Germany 16-Year Perspective for Pigmentation
Disorders Treatment by Treatment - Percentage Breakdown of
Value Sales for Topical Drugs, Laser Therapy, Chemical Peels,
Phototherapy, Microdermabrasion and Other Treatments for the
Years 2014, 2023 & 2030

Table 101: Germany Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 102: Germany Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 103: Germany 16-Year Perspective for Pigmentation
Disorders Treatment by Disease Indication - Percentage
Breakdown of Value Sales for Vitiligo, Albinism and Other
Disease Indications for the Years 2014, 2023 & 2030

Table 104: Germany Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 105: Germany Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 106: Germany 16-Year Perspective for Pigmentation
Disorders Treatment by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Aesthetic Clinics and Dermatology Centers
for the Years 2014, 2023 & 2030

ITALY
Table 107: Italy Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 108: Italy Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 109: Italy 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,
Microdermabrasion and Other Treatments for the Years 2014, 2023 &
2030

Table 110: Italy Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Disease Indication -
Vitiligo, Albinism and Other Disease Indications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 111: Italy Historic Review for Pigmentation Disorders
Treatment by Disease Indication - Vitiligo, Albinism and Other
Disease Indications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 112: Italy 16-Year Perspective for Pigmentation Disorders
Treatment by Disease Indication - Percentage Breakdown of Value
Sales for Vitiligo, Albinism and Other Disease Indications for
the Years 2014, 2023 & 2030

Table 113: Italy Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by End-Use - Hospitals,
Aesthetic Clinics and Dermatology Centers - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 114: Italy Historic Review for Pigmentation Disorders
Treatment by End-Use - Hospitals, Aesthetic Clinics and
Dermatology Centers Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 115: Italy 16-Year Perspective for Pigmentation Disorders
Treatment by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Aesthetic Clinics and Dermatology Centers for the
Years 2014, 2023 & 2030

UNITED KINGDOM
Pigmentation Disorders Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2023 (E)
Table 116: UK Recent Past, Current & Future Analysis for
Pigmentation Disorders Treatment by Treatment - Topical Drugs,
Laser Therapy, Chemical Peels, Phototherapy, Microdermabrasion
and Other Treatments - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Table 117: UK Historic Review for Pigmentation Disorders
Treatment by Treatment - Topical Drugs, Laser Therapy, Chemical
Peels, Phototherapy, Microdermabrasion and Other Treatments
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 118: UK 16-Year Perspective for Pigmentation Disorders
Treatment by Treatment - Percentage Breakdown of Value Sales
for Topical Drugs, Laser Therapy, Chemical Peels, Phototherapy,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06044794/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

              Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001